Company PharmaResources (Shanghai) Co., Ltd.

Equities

301230

CNE1000065Q9

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Ratings for PharmaResources (Shanghai) Co., Ltd.

EPS Revisions

Annual profits - Rate of surprise

Sector Other Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-07-15 pm EDT			5-day change	1st Jan Change
22.24 ^CNY	+1.92%		+1.60%	-19.24%

Jul. 15	Announcement of the Resolution of the Second Extraordinary General Meeting of Shareholders of PharmaRespurces Shanghai	CI
Jul. 03	Tranche Update on PharmaResources Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024.	CI

PharmaResources Shanghai Co Ltd is a China-based company mainly engaged in the development and commercial production of new drugs. The Company's main businesses include drug discovery, process research and development and commercial manufacturing business. The drug discovery business includes medicinal chemistry, synthetic chemistry and pharmacokinetics. The process research and development business includes process chemistry and process development as well as bulk drug research. The commercial manufacturing business includes customized manufacturing of new drugs and the research and development, production and sales of proprietary generic drug products. The Company distributes its products to the United States, India and other countries.

Number of employees: 1,047

CNY in Million	2022	Weight	2023	Weight	Delta
Drug Discovery 59.9 %	275	57.4 %	293	59.9 %	+6.73%
Commercial Production 22.3 %	117	24.5 %	109	22.3 %	-6.57%
Process Research and Development 15.9 %	80	16.8 %	78	15.9 %	-3.04%
Other 1.9 %	7	1.4 %	9	1.9 %	+36.64%

CNY in Million	2022	Weight	2023	Weight	Delta
Foreign 69.8 %	339	70.7 %	342	69.8 %	+1.00%
China 30.2 %	140	29.3 %	148	30.2 %	+5.30%

Managers	Title	Age	Since
Ping Chen CEO	Chief Executive Officer	66	07-12-13
Shi Cheng Li DFI	Director of Finance/CFO	47	14-07-31
Xiao Jing He BRD	Director/Board Member	38	09-06-30
Sheng Li Jiang BRD	Director/Board Member	53	07-11-30

Members of the board	Title	Age	Since
Qi Dong You BRD	Director/Board Member	69	20-07-31
Zheng Fei BRD	Director/Board Member	51	13-05-31
Sheng Li Jiang BRD	Director/Board Member	53	07-11-30
Rong Chang An BRD	Director/Board Member	59	13-12-31
Li Cheng BRD	Director/Board Member	53	20-04-30
Guo Dong Liu CHM	Chairman	46	17-07-31
Xue Jun Dong BRD	Director/Board Member	60	15-10-31
Hui Zu Wang BRD	Director/Board Member	36	18-11-30
Pei Hua Sun BRD	Director/Board Member	43	08-10-31
Xiao Jing He BRD	Director/Board Member	38	09-06-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	139,586,605	44,297,772 ( 31.73 %)	0	31.73 %

Name	Equities	%	Valuation
Zhong Ou Asset Management Co., Ltd 5.835 %	4,484,611	5.835 %	14 M ¥
Golden Trust Sinopac Fund Management Co., Ltd. 5.699 %	4,379,892	5.699 %	14 M ¥
Morgan Stanley Huaxin Fund Management Co., Ltd. 0.5650 %	434,278	0.5650 %	1 M ¥
Truvalue Asset Management Co. Ltd. 0.3459 %	265,824	0.3459 %	823 882 ¥
Huashang Fund Management Co., Ltd. 0.3026 %	232,545	0.3026 %	720 738 ¥
China Asset Management Co., Ltd. 0.2596 %	199,519	0.2596 %	618 379 ¥
Zhejiang Zheshang Securities Asset Management Co., Ltd. 0.1025 %	78,780	0.1025 %	244 167 ¥
JX Asset Management Co.,Ltd 0.0930 %	71,500	0.0930 %	221 604 ¥
Wanjia Asset Management Co., Ltd. 0.0574 %	44,089	0.0574 %	136 647 ¥
Fullgoal Fund Management Co., Ltd. 0.0563 %	43,290	0.0563 %	134 171 ¥

PharmaResources (Shanghai) Co., Ltd

Building 23 No. 315, Qingda Road

201201, Shanghai

http://www.pharmaresources.cn

address PharmaResources (Shanghai) Co., Ltd.(301230)

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

22.24

Average target price

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
PHARMARESOURCES (SHANGHAI) CO., LTD.	-19.24%	425M
MODERNA, INC.	+25.83%	47.96B
LONZA GROUP AG	+46.06%	41.47B
IQVIA HOLDINGS INC.	+0.69%	42.45B
ALNYLAM PHARMACEUTICALS, INC.	+30.52%	31.6B
ICON PUBLIC LIMITED COMPANY	+22.30%	28.63B
CELLTRION, INC.	-6.35%	28.03B
UNITED THERAPEUTICS CORPORATION	+49.25%	14.56B
MEDPACE HOLDINGS, INC.	+49.18%	14.14B
BIO-TECHNE CORPORATION	+3.45%	12.58B

Other Biotechnology & Medical Research